581 related articles for article (PubMed ID: 8700559)
1. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
2. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines.
Davies BR; Barraclough R; Rudland PS
Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
4. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line.
Chen H; Ke Y; Oates AJ; Barraclough R; Rudland PS
Oncogene; 1997 Apr; 14(13):1581-8. PubMed ID: 9129149
[TBL] [Abstract][Full Text] [Related]
5. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line.
Gao C; Mi Z; Guo H; Wei J; Wai PY; Kuo PC
Biochem Biophys Res Commun; 2004 Sep; 321(4):1010-6. PubMed ID: 15358129
[TBL] [Abstract][Full Text] [Related]
6. Generation of metastatic variants by transfection of a nonmetastatic rat mammary epithelial cell line with DNA from a metastatic rat mammary cell line.
Jamieson S; Barraclough R; Rudland PS
Pathobiology; 1990; 58(6):329-42. PubMed ID: 2078312
[TBL] [Abstract][Full Text] [Related]
7. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
8. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA transfer in the induction of metastasis in experimental mammary systems.
Barraclough R; Chen HJ; Davies BR; Davies MP; Ke Y; Lloyd BH; Oates A; Rudland PS
Biochem Soc Symp; 1998; 63():273-94. PubMed ID: 9513730
[TBL] [Abstract][Full Text] [Related]
10. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.
Kurisetty VV; Johnston PG; Johnston N; Erwin P; Crowe P; Fernig DG; Campbell FC; Anderson IP; Rudland PS; El-Tanani MK
Oncogene; 2008 Dec; 27(57):7139-49. PubMed ID: 18794800
[TBL] [Abstract][Full Text] [Related]
11. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
12. Identification of metaplastic variants generated by transfection of a nonmetastatic rat mammary epithelial cell line with DNA from a metastatic rat mammary cell line.
Jamieson S; Rudland PS
Am J Pathol; 1990 Sep; 137(3):629-41. PubMed ID: 1698029
[TBL] [Abstract][Full Text] [Related]
13. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Sung V; Gilles C; Murray A; Clarke R; Aaron AD; Azumi N; Thompson EW
Exp Cell Res; 1998 Jun; 241(2):273-84. PubMed ID: 9637769
[TBL] [Abstract][Full Text] [Related]
14. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas.
Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R
Cancer Res; 2005 May; 65(9):3796-805. PubMed ID: 15867376
[TBL] [Abstract][Full Text] [Related]
15. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
Murakami A; Tanaka H; Matsuzawa A
Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
Suzuki M; Mose E; Galloy C; Tarin D
Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.
Jessen KA; Liu SY; Tepper CG; Karrim J; McGoldrick ET; Rosner A; Munn RJ; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
Breast Cancer Res; 2004; 6(3):R157-69. PubMed ID: 15084239
[TBL] [Abstract][Full Text] [Related]
18. Lack of production of myoepithelial variants by cloned epithelial cell lines derived from the TMT-081 metastasizing rat mammary tumor.
Dunnington DJ; Kim U; Hughes CM; Monaghan P; Rudland PS
Cancer Res; 1984 Nov; 44(11):5338-46. PubMed ID: 6488188
[TBL] [Abstract][Full Text] [Related]
19. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells.
Dear TN; McDonald DA; Kefford RF
Cancer Res; 1989 Oct; 49(19):5323-8. PubMed ID: 2504488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
